SAS Output

26-APR-2018 6:10

MMYEL ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S1211-MM,High Risk, RVD+/-ELO 1 T 1 RVD/Elo Dose Level 1 110 8 0 0 0 0 0 02/13/2013 183 61
        4 RVD   68 0 0 0 0 0      
        5 RVD/Elo   66 0 0 0 0 0      
            142 0 0 0 0 0      
 
  S1304-MM,relapsed/refractory, Car+Dex 1 N 1 Dex+Low Dose Carfilzomib 140 72 0 0 0 0 0 02/12/2014    
        2 Dex+High Dose Carfilzomib   71 0 0 0 0 0      
            143 0 0 0 0 0      
 
    2 Y 3 Dex+High Dose Carfilzomib 140 22 0 0 0 0 0 02/12/2014    
            22 0 0 0 0 0      
 
  S0777-MM, Len Dex +/- Bortezomib 1 N 1 Lenalidomide/Dex 484 261 0 0 0 0 0 07/28/2008 5 1
        2 Bortezomib/Lenalidomide/Dex   264 0 0 0 0 0      
            525 0 0 0 0 0      
 
Yes E1A11-MM, frontline, BLD vs CLD 1 E Total Registrations   199 89 56 34 14 5 03/05/2014 302 129
            199 89 56 34 14 5      
 
No A061402-Solitary Plasmacytoma, adj sys+Zol vs Zol 0 E Total Registrations   1 0 0 0 0 0 01/27/2017    
            1 0 0 0 0 0      
 
  E1A11-MM, frontline, BLD vs CLD 0 E Total Registrations   219 100 62 37 12 2 03/05/2014 302 129
            219 100 62 37 12 2      
 
    2 E Total Registrations   61 36 19 12 4 0 03/05/2014    
            61 36 19 12 4 0      
 

26-APR-2018 6:10

MMYEL Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
S1702 AL Amyloidosis, Relapsed, Isatuximab 1 Initial Registration 08-Mar-18
S0777 MM, Len Dex +/- Bortezomib 2 Autologous Transplant 01-Apr-08